Recta radiotherapia est potissima methodus curationis cancri. Artificia radiotherapiae accurata, quae celeri fronte cultro, protona cultro, ion gravi, etc., radicali chirurgiae et auxiliari curationi aegroti cancri repraesentantur, praestare possunt. To understand the progress of radiotherapy, sarcoma is more common in young people, is a malignant tumor derived from mesenchymal tissue (including connective tissue and muscle). Sarcomas are highly malignant and develop rapidly! Common sarcomas include osteosarcoma, leiomyoma, lymphosarcoma, synovial sarcoma, etc.
Methodus sarcoma chirurgica praeferenda est. Ad sanationem radicalem quaerendam, medici domestici aegros abscindere solent, ut membra sua abscindantur. , plerique aegroti difficiles curant. Sarcoma chemotherapy non sentit. Ordinarius Rectum est etiam difficile ad occidere secretiori parte natium: et leiomyoma, lymphosarcoma et SARCOMA vagina synovialis metastasis per quam prona est sanguis. Unde oportet quod in curatio de SARCOMA quam primum et quam primum.
The EDGE Radiosurgery system (EDGE radiosurgery tuberculum treatment system) was developed by the American Varian company and was approved by the US FDA on January 23, 2013. The EDGE blade is by far the most effective non-invasive tumor removal technology, using the unique FDA’s Calypso® GPS for the Body® system and surface beam monitoring system approved on July 21, 2014 with high-frequency real-time dynamics of up to 10 ms Monitor and lock the tumor “escape” during the treatment process, combined with the new generation IGRT and other image guidance technology, using the unique high-intensity HD-MLC collimator up to 2400MU / min to remove tumor tissue with sub-millimeter accuracy with almost no residue .
Singularis notae ACIES cultri velocitatis, radiatio altae intensionis usque ad 2400MU/min, celeriter DNA cellularum tumoris frangere potest, ac demum causa cellae tumoris mori et tumor vel cicatrice absorptus est. Quod recte ACIES de cultro tam altus quam 0.1mm.
